This unique event will bring the key scientific highlights of ESC Congress 2025 directly to cardiology professionals in China who may not have been able to attend the Congress in Madrid.

Participants will have the opportunity to:

• Engage with leading ESC experts on applying the latest insights in a local context
• Explore the most recent ESC Guidelines
• Review landmark clinical trials and their impact on daily practice
• Discuss topics of particular relevance to cardiology in China

With this initiative, the ESC aims to make cutting-edge cardiovascular education more accessible worldwide, extending the reach of new knowledge to countries where joining ESC Congress in person is a challenge.

We look forward to welcoming you to Beijing for this inspiring exchange of knowledge and practice.

Register for GWICC 2025

 *To attend Best of ESC Congress 2025, registration for GWICC 2025 is required*

Discover the Scientific Programme:

Session 1  / Landmark, Hotline & Late Breaking Trials - Heart Failure 

Session Pathway: Heart Failure and Cardiomyopathy
Chairs: Franz Weidinger, Jianzeng Dong, Jian Zhang, Yihong Sun, Qing Zhang

8:30 - 8:50 | Pascal Vranckx – DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure 

8:50 - 9:10 | Tomasz Guzik – ESC Hotline Trials: Vericiguat in Heart Failure (VICTOR, VICTORIA) and Baxdrostat in Resistant Hypertension (BaxHTN)

9:10 - 9:30 | Christian Hassager – DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

Discussion (30 mins)

Session 2 / Landmark, Hotline & Late Breaking Trials – Beta blockers

Session Pathway: Coronary Heart Disease
Chairs: Franz Weidinger, Christian Hassager, Yaling Han, Jun Zhu, Dingli Xu, Jingbo Hou

10:30 - 10:55 | Eva Prescott – Re-Evaluating Beta-Blocker Therapy After MI Without Heart Failure: Data from BETAMI/DANBLOCK, REBOOT and a Pooled Meta-analysis

10:55 - 11:10 | Filippo Crea – REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function

Discussion (30 mins)

Session 3 / 2025 ESC/EACTS Guidelines for the management of valvular heart disease

Session Pathway: Valvular Heart Disease and Congenital Heart Disease / Pulmonary Vascular Disease
Chairs: Christian Hassager, Franz Weidinger, Xiangqing Kong, Yongjian Wu, Guangyuan Song, Mao Chen

14:00 - 14:20 | Alessia Gimelli –What do the Guidelines say?

14:20 - 14:40 | Fabien Praz – How to implement the Guidelines? (online)

Discussion (30–50 mins)

Session 4 / 2025 ESC Guidelines for the management of myocarditis and pericarditis

Session Pathway: Valvular Heart Disease and Congenital Heart Disease / Pulmonary Vascular Disease
Chairs: Franz Weidinger, Eva Prescott, Xin Du, Daowen Wang, Yunlong Xia (Ying Liu)

16:00 - 16:20 | Jeanette Schulz-Menger – Focus on Myocarditis: What do the Guidelines say (online)

16:20 - 16:40 | Massimo Imazio – How to implement the Guidelines? (online)

Discussion (20 mins)

At the end of the last session

17:00 - 17:20 | Franz Weidinger – Wrap up & key messages

17:20 - 17:40 | Ceremony – FESC Convocation